The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 3155 -3164
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0801710

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acosta-Iborra, B.
Right arrow Articles by Landázuri, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Acosta-Iborra, B.
Right arrow Articles by Landázuri, M. O.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN

Macrophage Oxygen Sensing Modulates Antigen Presentation and Phagocytic Functions Involving IFN-{gamma} Production through the HIF-1{alpha} Transcription Factor1

Bárbara Acosta-Iborra2,*, Ainara Elorza2,*, Isabel M. Olazabal2,*, Noa B. Martín-Cofreces*, Silvia Martin-Puig*, Marta Miró{dagger}, María J. Calzada*, Julián Aragonés*, Francisco Sánchez-Madrid*,{ddagger} and Manuel O. Landázuri3,*

* Servicio de Inmunología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid; {dagger} Gabinete Veterinario, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid; {ddagger} Departamento de Biología Vascular e Inflamación, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain

Low oxygen tension areas are found in inflamed or diseased tissues where hypoxic cells induce survival pathways by regulating the hypoxia-inducible transcription factor (HIF). Macrophages are essential regulators of inflammation and, therefore, we have analyzed their response to hypoxia. Murine peritoneal elicited macrophages cultured under hypoxia produced higher levels of IFN-{gamma} and IL-12 mRNA and protein than those cultured under normoxia. A similar IFN-{gamma} increment was obtained with in vivo models using macrophages from mice exposed to atmospheric hypoxia. Our studies showed that IFN-{gamma} induction was mediated through HIF-1{alpha} binding to its promoter on a new functional hypoxia response element. The requirement of HIF-{alpha} in the IFN-{gamma} induction was confirmed in RAW264.7 cells, where HIF-1{alpha} was knocked down, as well as in resident HIF-1{alpha} null macrophages. Moreover, Ag presentation capacity was enhanced in hypoxia through the up-regulation of costimulatory and Ag-presenting receptor expression. Hypoxic macrophages generated productive immune synapses with CD8 T cells that were more efficient for activation of TCR/CD3{epsilon}, CD3{zeta} and linker for activation of T cell phosphorylation, and T cell cytokine production. In addition, hypoxic macrophages bound opsonized particles with a higher efficiency, increasing their phagocytic uptake, through the up-regulated expression of phagocytic receptors. These hypoxia-increased immune responses were markedly reduced in HIF-1{alpha}- and in IFN-{gamma}-silenced macrophages, indicating a link between HIF-1{alpha} and IFN-{gamma} in the functional responses of macrophages to hypoxia. Our data underscore an important role of hypoxia in the activation of macrophage cytokine production, Ag-presenting activity, and phagocytic activity due to an HIF-1{alpha}-mediated increase in IFN-{gamma} levels.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Migration and Inflammation Network UAMAD04 and Comision Interministerial de Ciencia y Tecnologia (to M.O.L.) and Red Temática de Enfermedades Cardiovasculares (RD06/0014/0031 to M.O.L., RD06/0014/0030 to F.S.-M., and fellowship for M.M.). B.A.-I. is an investigator from the Ministerio de Educación y Ciencia. A.E. is from the Ministerio de Salud y Consumo. I.M.O., M.J.C., and J.A. are investigators from the Ministerio de Ciencia y Tecnología Programa Ramón y Cajal.

2 B.A.-I., A.E., and I.M.O. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Manuel O. Landázuri, Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, C/ Diego de León, 62, E-28006, Madrid, Spain. E-mail address: mortiz.hlpr{at}salud.madrid.org

4 Abbreviations used in this paper: HIF, hypoxia-inducible factor; PHD, prolyl hydroxylase domain; VEGF, vascular endothelial growth factor; IS, immune synapse; MTOC, microtubule-organizing center; HRE, hypoxia response element; LAT, linker for activation of T cells; MHC-I/II, MHC class I/II; RT, real time; siRNA, small interfering RNA; ChIP, chromatin immunoprecipitation; siSCR, scrambled siRNA; OVAp, OVA peptide; Glut-1, glucose transporter type-1; DMOG, dimethyloxalylglycine.

5 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.